chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving vaccine developed dizziness and hypotension, then developed itchiness in throat.  EPI pen was administered and emergency response team called.   She was transported to the Emergency Room for treatment.  She was treated with steroids and antihistamines.  Diagnosed with anaphylactic reaction. Discharged with EpiPen, albuterol inhaler prn, and steroid taper.
This spontaneous report as received from a consumer via MSW research refers to her unspecified friends of unknown age and gender. On an unknown date, the unspecified patients were vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (dosing details were unknown). Concomitant medication were unknown. On an unknown date, the patients did not do so well (adverse event) after getting their shot. The outcome of event was unknown. The relatedness of the event with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) was not provided. Additional information is not expected as there was no consent to follow up.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider(s) recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2013, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2014, the patient was treated by a healthcare provider at a medical center for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Causality assessment considered events to be related to the use of ZOSTAVAX. Additional information has been requested.
Administered Pediarix (4th dose) and Rotarix (3rd dose) extra doses to a 12 month old patient; Administered Pediarix (4th dose) and Rotarix (3rd dose) extra doses to a 12 month old patient; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 1-year-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number X9HS4, expiry date 17th February 2024) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis, Rota (Rotarix lyophilized formulation) (batch number M4AR7, expiry date 6th July 2023) for prophylaxis and rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis.   On 4th May 2022, the patient received the 4th dose of Pediarix, Pediarix Pre-Filled Syringe Device, the 3rd dose of Rotarix lyophilized formulation (oral) and Rotarix Oral Applicator Device. On 4th May 2022, unknown after receiving Pediarix, Pediarix Pre-Filled Syringe Device, Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced extra dose administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the extra dose administered and inappropriate age at vaccine administration were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 04-MAY-2022 Reporter's comment: Registered Nurse (RN) enquired, how to proceed and asked for guidance, as on the day of reporting, they inadvertently administered Pediarix (4th dose) in left vastus lateralis and Rotarix (3rd dose) extra doses to a 1 year old patient. RN stated it was not supposed to administer the Pediarix and Rotarix. Consented to follow up. Additional Supportive Information: The 1 year old patient received 4th dose of Pediarix, which led to extra dose administered and 3rd dose of Rotarix, which led to extra dose administered and inappropriate age at vaccine administration.
Pain for the arthritis; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Pain for the arthritis) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis, Heart disease, unspecified and Blood pressure. Concomitant products included MELOXICAM for Arthritis.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (Pain for the arthritis). At the time of the report, ARTHRITIS (Pain for the arthritis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medicines included medication for arthritis, heart and blood pressure medicine. No treatment information was reported.
pt became dizzy, nauseous, c/o headache. was transferred to ED for evaluation by Dr. and was alert and oriented at that time w/o respitory distress.
Pt recvd DTP/HIB/OPV on 11FEB91; next morning mom reported that pt had a discoloration of thigh where HIBTITER was given; @ 4 mo visit 7APR91, pt still had discoloration of whole upper thigh which began @ diaper area & down to the knee;
It was reported that a 46 year old patient received a Fluzone SV '01-'02 vaccination, lot UO588AA, date of administration not specified. Sometime after the vaccination, the patient developed a very sore shoulder on same side as injection with swelling and redness at the shoulder area but no reaction at the injection site. Patient was seen in physician's office.
The patient experienced a "petty mal" seizure while receiving flu vaccination. His wife was standing next to him and said, he usually had these when he is under stress." Usually 2 or 3x per week this occurs per the patient. He sat on bench for several minutes. Report he is ok.
Fever of 101 for the first 48 hrs, ibuprofen, fever went down Pain in the arm for first 24 hrs, ice, ibuprofen, pain went away
Mother reports she noticed a rash on patient's right thigh this AM. She had immunizations about 1 1/2 weeks ago and 3 days ago mother noticed a "nickel sized lump" on right thigh which is reddened. Was diagnosed with ear infection 1 week ago and started on AUGMENTIN. Did have a fever last week but none since 02/12. Normal appetite and fluid intake.
reddish rash and swelling, similar to a hive, silver-dollar sized...appeared at least within 48 hrs of immunization
Headache; Nausea; This is a spontaneous report from a non-contactable Other Health Professional reported for patient. A 26-year-old female patient BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6206, Expiration date: Unknown), via an unspecified route of administration on an unknown date (at the age of 26-year-old) as 1st dose, single dose for COVID-19 immunization. Medical history included dental work and as a corrective measure took ibuprofen at 600 mg, tylenol 500 mg and applied ice pack as well on the neck. Concomitant medications included Ibuprofen at 600 mg and Tylenol at 500mg. On an unknown date, during her 15 minutes waiting period after the injection, the patient had experienced headache and nausea. She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. Patient received treatment included water, Tylenol at 500 mg, Ibuprofen at 200 mg and Pepcid at 20 mg. Symptoms was improving with medication treatments as listed. She felt comfortable going home and monitored in the bay for 25 minutes. Follow up response to treatment was good. Patient was discharge as stable to go home. She denied any concerns. Follow up with pcp as needed. Differential diagnosis reported as "red flag symptoms (CP, SOB, NVD, Visual/Neuro concerns)". The outcome of nausea was resolved, and headache was unknown.  No follow-up attempts are possible; no further information is expected.
Pt states she is "experiencing side effects" from the Moderna COVID vaccine. Has felt the following symptoms on and off since 09/30/2021: elevated BP 129-150/90s (on HCTZ - not previously well-controlled) lightheaded, dizzy burning in her chest fatigue body aches  brain fog  Following up with PCP to determine if other process is causing these symptoms.
Pt received vax on 01/06/2000. Subsequently she discovered she was 03/01/2000. She is approximately 4 weeks. PHN advised that she speak with OBGYN/prenatal care physician and that the risk of birth defects is theoretical.
12/29/2021: Event occurred after 2nd vaccine.    40-year-old male history of EtOH abuse with a history of seizures and DTs otherwise healthy presents emergency department for witnessed seizure that occurred earlier tonight.  Not on any nausea or vomiting at this time.  No fever or chills.  No chest pain or shortness of breath.  No other complaints.
Chest Pain-ongoing tongue tingling- lasted  1 week Lightheaded- ongoing dizzyness - ongoing arm weakness and soreness- ongoing
Pfizer-BioNTech COVID-19 Vaccine EUA Started with some headache 30 minutes after the vaccine and the following day in the afternoon the fever started (high 40/41C), nausea and intense body aches.   These symptoms lasted until Monday (2 full days).  Today is the 3rd day, and still with body aches a little nausea, very painful and warm arm but no fever. This was the first dose but the patient had Covid in March of 2020 ( at the time all the symptoms mentioned above were present with the addition of having lost taste and having some hallucinations.   No problem breathing.     Just letting you know for the purpose of statistics.
Aching pain through arm 2hrs post vaccine No fever but skin felt hot on entire body 4hrs post vaccine  Full body aches 4hrs post vaccine  Fatigue (felt incredibly sleepy) 6hrs post vaccine   All symptoms stopped 48hrs after vaccine
I recieved my moderna booster on Jan. 6th, 2022. 10 days after receiving it on Jan 16th I broke out itching everywhere with a rash that turned into hives. Still today Feb. 4th I continue to itch and break out in rashes everywhere. It is ver uncomfortable. I had to receive a steriod injection to help calm it down. It helped a little bit, but now it's starting to get itchy again. I take Zyrtec daily and benadryl at night to help with the itching.
101 F fever, very sore arm at injection site (last for 2 days) and couldn?t  lift arm it hurt so bad.  Full body aches for 2 full days,  chills, and severe  headache for 2 days.  I still have the headache at day 3, but other symptoms seem to be subsiding.
This spontaneous report as received from a medical assistant refers to a 4 year old patient of unknown gender. On an unknown date in April 2014, between 12-APR-2014 and 24-APR-2014, the patient was vaccinated with a dose of VARIVAX (Merck) lot # J006358, expiry 23-MAY-2015 ("VFC" stock), 0.5 ml, once, intramuscular. The medical assistant stated there was a power outage on 12-APR-2014 and the VARIVAX (Merck) doses from the freezer needed to be transported to unspecified hospital for proper storage. She stated VARIVAX (Merck) was exposed to 46F for 1 hour, at worst. There were no prior excursions. There was a site visit from local health department on an unspecified date. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt. states that after receiving the 2nd dose of Phizer 03/30/2021, started experiencing symptoms 04/12/2021 liver enzymes have gone up along with blood pressure reading. Rash appearing all around the thighs and legs with swelling, continuing to appear throughout the body. 04/13/2021 Primary visit, 06/14/021 Primary visit with Prednisone prescribed, and 07/20/2021 Primary continuing the previous prescription.
When client stood up, stated "I feel funny had her sit back down, when she sit down she then fainted-nurse lowered her to ground to lie with feet elevated. Client then woke with pupils dilated to 8. Oriented x 3. Pulse - 90 Resp 18 124/84 - After client rested for 15 min B/P 116/64 Pulse 74 Resp 16. Client states she did not eat breakfast or lunch today. Drank glass of water, 15 mins later 110/60 Resp 16 Pulse 70 strong and regular. Denies all s/s-states just feels tired. Client states had nausea on 8/16 at theme park, pupils not dilated-escorted to car per grandmother.
pt recvd 2 doses of Engerix-B & 2 hrs p/2nd dose devel itching, & red patch on both elbows, back knees, palms of hands & lt inner wrist;
Patient also received flu shot but was not given information on the lot #, brand, etc.  On December 6, at 2:30pm patient started experiencing symptoms of migraine (onset within 30 minutes).  This is patient's first migraine.  Patient was seen at the ER on December 8 and administered sodium chloride, dexamethasone PF, diphenhydramine, ketorolac, metoclopramide, and olanzapine.  Pain was reduced some but not resolved  and client was discharged.  Patient saw PCP on 12/10 and was given Fioricet and Zofran, which was taken from 12/10 until 12/13 but did not resolve the migraine.  On 12/13 patient was given Imitrex, Verapamil and Fioricet; treatment results are pending.  Patient does not have a history of migraines or significant headaches.
Information has been received from a physician concerning a 15 year old female patient who on 16-AUG-2008, was vaccinated subcutaneously into the left arm with a second dose of VARIVAX (Oka/Merck) (lot # 660495/0431X).  On 18-AUG-2008, when she woke up, the patient notice a large area of swelling and redness at the site of injection.  Patient was advised to apply cold compresses and use MOTRIN and TYLENOL for discomfort and call back if reaction doesn't disappear in 24- 48 hours.  Her outcome was unknown.  No further information is available.
Information has been received from a medical assistant referring to a 59 years old female patient. The patient had no illness at the time of vaccination. There has no pre-existing physician-diagnosed allergies, birth defects or medical conditions. Information about concomitant medication was not provided. The reporter reported that on 08-FEB-2019, the patient received a dose of PNEUMOVAX 23 (lot # N014946, expiration date was 01-FEB-2019, intramuscular in right (R) Deltoid; strength and dose were not reported) for prophylaxis in a private doctor's office/hospital after its labeled expiration date. No adverse effects or reaction were reported in the patient. No prescription drug treatment was required for the experience. Vaccine was purchased with private funds. No temperature excursion occurred as a result of a reading from a digital data logger. No other vaccination within 4 weeks prior to the date of vaccination.
Was informed that pt. developed red rash about 20 minutes after receiving immunizations. Episode lasted for about 1 and 1/2 hours. Pt vomited x 1 after arriving home.
Body aches; Fever; Red rashes at injection sites; Red rashes at injection sites; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PYREXIA (Fever), INJECTION SITE ERYTHEMA (Red rashes at injection sites) and INJECTION SITE RASH (Red rashes at injection sites) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Crohn's disease.    No Medical History information was reported.   On 18-Aug-2021, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 25-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In August 2021, the patient experienced PAIN (Body aches), PYREXIA (Fever), INJECTION SITE ERYTHEMA (Red rashes at injection sites) and INJECTION SITE RASH (Red rashes at injection sites). In August 2021, PAIN (Body aches) and PYREXIA (Fever) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (Red rashes at injection sites) and INJECTION SITE RASH (Red rashes at injection sites) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No concomitant medication was reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Primary reporter did not have the lot number information, because the packaging was discarded.  No treatment medication was reported.  The reporter's causality for the events of body aches and fever with Humira (adalimumab) was no reasonable possibility. The reporter's causality for the events of red rashes at injection sites onset in August 2021 and red rashes at injection sites onset in August 2021 with Humira (adalimumab) was a reasonable possibility.
Janssen COVID-19 EUA  !.  Sudden onset varicose veins ? ropey, bulging, distended? ankle pain at night. 2.  Intense, painful throbbing at temples? intermittent. 3.  Stomach ache near diaphragm? intermittent. 4.  Lower abdominal ache behind pubic bone? intermittent. 5.  Swift decline in eyesight? greatly reduced contrast, blurriness, double vision. 6.  Sudden appearance of small red dots beneath skin on legs? petechiae. 7.  Significant herpes reinfection. 8.  Fatigue and consequential decline in energy.
Severe nausea, temperature 102, aches, chills, severe headache, light sensitivity On 03/19/2021, consulted with Dr and given Rx for Ondansetran, 8mg Symptoms receed over the next few hours
Patient received Fluad @ approx 2:45pm. In a few minutes she complained of dizziness and feeling unwell while seated. Patient had no history of allergic reaction to flu shot and has been getting flu shot in the past.  Patient initially declined us calling ambulance for her. Patient stated she has high pressure and her blood pressure was elevated upon checking. She stated she was feeling better and would just remain seated with her friend. When the pharmacist checked back with her she agreed to get ambulance called as she was feeling dizzy and had a headache. Paramedic came and performed the checkups. Patient stayed in the pharmacy area and left when she was feeling fine.
By the time I left the parking lot I started feeling numbness starting on left side of face between hairline and left eye all the way to my lip, and down to my chin, drove home as fast as I could. By the time I got home, I had chills, nausea. A very mild numbness persisted for a few days. I had powdered Tylenol by my bed that I consistently took every 6 hours, fevers still reached 104. These symptoms lasted full 3 days, just a little longer than the first two. I still had numbness for two months afterwards, for it slowly going away. Similar to coming off of Novocain. I still have some numbness in left side area by my lip.
Rash over trunks, papules, few pustule no vesicles or crusting. Resolved quickly with no particular treatment. Was diagnosed as chicken pox by urgent care doctor.
Temperature 101.9 rectal.  Hives.  Rx ROCEPHIN 350 mg IM.
Patient reports arm the had injection is swollen, red and hot, with itching around injection site.  Patient reports red area is the size of a coffee saucer.  Patient also reports bruising at injection site.    Patient reports this started the morning after the injection and continues today 10-21-19. Patient reports that she took Zyrtec for the itching.  Advised patient to call and discuss this with her Primary care Physician, and they could decide on further treatment.
Constant pain in arm since the first shot, the pain has gotten worse over time. Throbbing pain in the arm, the worst time is in the morning. The rest of the time it feels like I was punched in the arm.
02/13/22 presents to EC ED for "dizziness". "no known pmhx"
Patient c/o pain and swelling at right deltoid injection site.  Noticeable swelling, warmth and tenderness to touch noted.  Ice applied and physician notified.  Benadryl 50 mg. po x 1 ordered and repeat in 1 hour if needed and was given for a total of 100 mg. po.  Hydrocortisone 1% cream ordered and applied topically to site.
5 days after I got the shot my eyes started to get swollen and red eyelids.  Went to my doctor on Tuesday (1 week) after the shot and she prescribed steroids, did not worked, 2 antibiotics did not worked, all blood work is normal.  Two weeks after i started with symptoms my eyes are worst than ever.  Eye doctor cleared me of infections.
Red, raised rash over body except face, hands and feet. Doctor saw pt on Thursday, 11/9/00. He stated pt was having a severe drug reaction. He ordered methylprednisolone pack.
Client reports receiving MMR on 07/26/2006.  She notes that she experienced myalgias that night and has subsequently had bilateral ankle pain and pain, stiffness and swelling of her hands.  She reported this to Health Services on 08/18/2006.
Individual reported body aches and extreme lower back pain near the spine.  Lower back pain was reported to of occurred initially as minor two hours after receiving the injection and got worse.  The back pain is still on going in the person and continued for 48 hours.  Curious if linked to taking valaciclovir as the person did not recall hurting their back during the course of the day.  Individual is in excellent health and physically fit.
Patient was ordered Pneumovax per physician orders. Patient was given injection on 12/9/06 in the left arm at 1213. On 12/11/06 the patient complained to nursing of a throbbing pain at the injection site. Area appeared to be bruised and firm to the touch. Over the next few days the patient continued to complain of pain at the injection site and was given pain medications per orders. On 12/18/06 the area was red with a 1.5cm yellow slough and a white center. The wound care nurse described this as a bulla with atropical center and erythematic peri wound 3cm across. Patient also later received antibiotics for possible cellulitis. Symptoms eventually began to resolve.
Knee joint pain. Woke up several times throughout the night from the pain in my knees. Took Tylenol and  Epsom salt baths. for the pain. Trying to work them. Horrible headache. Body aches, and fatigue.
Pt described vaccine being given near elbow and has been painful ever since it was given on 11/18/16. Going to a neurologist hard to raise arm.
I received my Vaccine on 1/19/2021, on Friday 1/22/2021 my arm pit/Lymph node started to hurt. Then one week later on 1/26/2021 I started having vaccine shoulder itchiness I didn't think anything of it and then my arm swelled and got hot. The next day on 1/27/2021 it had a red area around it and was hot. I have never had a fever or anything else except minor pain the day after the vaccine.  I continued ibuprofen and benadryl at night it took the itch away and was bearable. I want to know if I should get the second shot? I have it scheduled for 2-15-2021 @ 2:00 pm PST I also have pictures